InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Millar Kerri-Ann, 首席财务官. Insider active across 1 company, notably Cue Biopharma, Inc.. Cumulatively, 2 filings have been logged. History available since 23 August 2021. The latest transaction was filed on 23 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Kerri-Ann Millar serves as Chief Financial Officer at Cue Biopharma, Inc. She is responsible for the financial management of the company, including budgeting and performance analysis. Her role also involves overseeing financial reporting and regulatory compliance. With a strong background in the industry, she contributes to the overall financial strategy of the company.